Akron Biotechnology's (AKRBY.US) stock price, as an over-the-counter (OTC) traded security, is influenced by several factors:

Company Performance: Financial health, revenue growth, and profitability directly impact investor confidence.

Industry Trends: Developments in the biopharmaceutical sector, especially cell and gene therapy, significantly affect valuation.

Regulatory Environment: Changes in regulations governing biologics manufacturing and clinical trials can create uncertainty or opportunity.

Market Sentiment: Overall investor optimism or pessimism regarding biotech stocks impacts trading activity and valuation.

Competition: The presence and actions of competing companies in the regenerative medicine space affects market share and pricing power.

News and Announcements: Press releases regarding partnerships, product development milestones, or clinical trial results affect market reaction.

Economic Conditions: Macroeconomic factors such as interest rates and inflation can affect overall investment appetite and valuation of growth stocks.

Liquidity and Trading Volume: Lower trading volume on OTC markets can lead to higher price volatility and wider bid-ask spreads.

Dilution: Issuance of new shares can dilute existing shareholders' value and affect stock price.

Intellectual Property: Strength and breadth of patent portfolio for cell and gene therapy manufacturing processes affect the long-term value of the firm.